Approaches for dosage individualisation in critically ill patients

Author： Fernández de Gatta Ma del Mar   Martin-Suarez Ana   Lanao Jose M  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.11, 2013-11, pp. : 1481-1493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Normoglycaemia benefits critically ill patients

By  

Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of fluconazole in critically ill patients

By Sinnollareddy Mahipal   Peake Sandra L   Roberts Michael S   Playford E Geoffrey   Lipman Jeffrey   Roberts Jason A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1431-1440

Informa Healthcare

Access to resources Recommend Favorite

Clinical Potential of Insulin Therapy in Critically Ill Patients

By Mesotten D.   Berghe G.V.d.  

Drugs, Vol. 63, Iss. 7, 2003-01 ,pp. : 625-636

Adis International

Access to resources Recommend Favorite

Plasma Pharmacokinetics of Antimicrobial Agents in Critically Ill Patients

By  

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 5-12

Bentham Science Publishers

Access to resources Recommend Favorite

Antimicrobial Drug Interactions in the Critically Ill Patients

By  

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 25-38

Bentham Science Publishers

Access to resources Recommend Favorite